156 related articles for article (PubMed ID: 3035459)
1. Chemotherapy for salivary gland cancer.
Kaplan MJ; Johns ME; Cantrell RW
Otolaryngol Head Neck Surg; 1986 Sep; 95(2):165-70. PubMed ID: 3035459
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancer.
Debaere D; Vander Poorten V; Nuyts S; Hauben E; Schoenaers J; Schöffski P; Clement PM
B-ENT; 2011; 7(1):1-6. PubMed ID: 21563549
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin.
Dreyfuss AI; Clark JR; Fallon BG; Posner MR; Norris CM; Miller D
Cancer; 1987 Dec; 60(12):2869-72. PubMed ID: 2824016
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for salivary gland cancer.
Suen JY; Johns ME
Laryngoscope; 1982 Mar; 92(3):235-9. PubMed ID: 6279995
[TBL] [Abstract][Full Text] [Related]
5. Preliminary experience with chemotherapy in advanced salivary gland neoplasms.
Belani CP; Eisenberger MA; Gray WC
Med Pediatr Oncol; 1988; 16(3):197-202. PubMed ID: 2837623
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland.
Airoldi M; Pedani F; Brando V; Gabriele P; Giordano C
Tumori; 1989 Jun; 75(3):252-6. PubMed ID: 2475951
[TBL] [Abstract][Full Text] [Related]
7. Vinorelbine treatment of recurrent salivary gland carcinomas.
Airoldi M; Bumma C; Bertetto O; Gabriele P; Succo G; Pedani F
Bull Cancer; 1998 Oct; 85(10):892-4. PubMed ID: 9835866
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
Kim Y; Lee SJ; Lee JY; Lee SH; Sun JM; Park K; An HJ; Cho JY; Kang EJ; Lee HY; Kim J; Keam B; Kim HR; Lee KE; Choi MY; Lee KH; Ahn MJ
Cancer; 2017 Jun; 123(11):1958-1964. PubMed ID: 28102887
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group.
Venook AP; Tseng A; Meyers FJ; Silverberg I; Boles R; Fu KK; Jacobs CD
J Clin Oncol; 1987 Jun; 5(6):951-5. PubMed ID: 3585449
[TBL] [Abstract][Full Text] [Related]
10. Systemic therapy in the management of metastatic or advanced salivary gland cancers.
Lagha A; Chraiet N; Ayadi M; Krimi S; Allani B; Rifi H; Raies H; Mezlini A
Oral Oncol; 2012 Oct; 48(10):948-957. PubMed ID: 22698431
[TBL] [Abstract][Full Text] [Related]
11. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.
Dodd RL; Slevin NJ
Oral Oncol; 2006 Sep; 42(8):759-69. PubMed ID: 16757203
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for recurrent salivary gland malignancies: experience of the ENT Department of Turin University.
Airoldi M; Brando V; Giordano C; Gabriele P; Bussi M; Cortesina G
ORL J Otorhinolaryngol Relat Spec; 1994; 56(2):105-11. PubMed ID: 8177583
[TBL] [Abstract][Full Text] [Related]
13. Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma.
Ross PJ; Teoh EM; A'hern RP; Rhys-Evans PH; Harrington KJ; Nutting CM; Gore ME
Clin Oncol (R Coll Radiol); 2009 May; 21(4):311-4. PubMed ID: 19201585
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.
Ghosal N; Mais K; Shenjere P; Julyan P; Hastings D; Ward T; Ryder WD; Bruce I; Homer J; Slevin NJ
Br J Oral Maxillofac Surg; 2011 Oct; 49(7):510-5. PubMed ID: 21071117
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group.
Gilbert J; Li Y; Pinto HA; Jennings T; Kies MS; Silverman P; Forastiere AA
Head Neck; 2006 Mar; 28(3):197-204. PubMed ID: 16470745
[TBL] [Abstract][Full Text] [Related]
16. A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer.
Kim HR; Lee SJ; Park S; Jung HA; Lee SH; Jeong HS; Chung MK; Ahn MJ
Cancer Res Treat; 2022 Jul; 54(3):719-727. PubMed ID: 34727492
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin combination chemotherapy in squamous cell carcinoma and adenoid cystic carcinoma of the skin.
Ikegawa S; Saida T; Obayashi H; Sasaki A; Esumi H; Ikeda S; Kiyohara Y; Hayasaka K; Ishihara K
J Dermatol; 1989 Jun; 16(3):227-30. PubMed ID: 2551943
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of malignant major salivary gland neoplasms: a 25-year review of M. D. Anderson Hospital experience.
Rentschler R; Burgess MA; Byers R
Cancer; 1977 Aug; 40(2):619-24. PubMed ID: 196735
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of the combination of 5 fluorouracil, adriamycin and cisplatin (FAP protocol) in the treatment of metastatic cylindroma. Apropos of a case with review of the literature].
Farhat F; Kattan J; Culine S; Bekradda M; Droz JP
Bull Cancer; 1994 Jan; 81(1):47-50. PubMed ID: 7949584
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
